Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Depreciation and Depletion (2016 - 2020)

Historic Depreciation and Depletion for Champions Oncology (CSBR) over the last 11 years, with Q4 2020 value amounting to $254000.0.

  • Champions Oncology's Depreciation and Depletion rose 5679.01% to $254000.0 in Q4 2020 from the same period last year, while for Oct 2020 it was $313000.0, marking a year-over-year increase of 5888.32%. This contributed to the annual value of $150000.0 for FY2025, which is 273.97% up from last year.
  • Per Champions Oncology's latest filing, its Depreciation and Depletion stood at $254000.0 for Q4 2020, which was up 5679.01% from $224000.0 recorded in Q3 2020.
  • Champions Oncology's Depreciation and Depletion's 5-year high stood at $254000.0 during Q4 2020, with a 5-year trough of -$349000.0 in Q2 2020.
  • For the 5-year period, Champions Oncology's Depreciation and Depletion averaged around $64176.5, with its median value being $98000.0 (2018).
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first surged by 20833.33% in 2018, then plummeted by 4725.74% in 2020.
  • Champions Oncology's Depreciation and Depletion (Quarter) stood at $34000.0 in 2016, then surged by 144.12% to $83000.0 in 2017, then skyrocketed by 38.55% to $115000.0 in 2018, then surged by 40.87% to $162000.0 in 2019, then surged by 56.79% to $254000.0 in 2020.
  • Its last three reported values are $254000.0 in Q4 2020, $224000.0 for Q3 2020, and -$349000.0 during Q2 2020.